Dexcom G6 Continuous Glucose Monitoring System Launches in Singapore

Hitesh
thehealthco.info
Dexcom, Inc., the global leader in Real-Time Continuous Blood Sugar Monitoring (CGM) for Diabetics, today announced the launch of the Dexcom G6 CGM System in Singapore for those people with diabetes aged two years and over, including pregnant women, and the appointment of DKSH Singapore Pte Ltd as a sales, marketing and distribution service provider.The Dexcom G6 uses a small, wearable transmitter and sensor to continuously measure and wirelessly send blood glucose levels to a compatible receiver or smart device*, allowing patients to receive real-time blood glucose data real-time without needing to prick their finger†. The system also provides customizable alerts and warnings to help avoid dangerous hypoglycemia and hyperglycemia events.
“The launch of Dexcom G6 in Singapore is a significant milestone for our company,”
“This launch marks the first time Dexcom CGM is available to people living with diabetes in Southeast Asia, and with the recent opening of our regional headquarters in Singapore, we look forward to bringing Dexcom CGM to additional markets in the region in the near future.”
Scott Moss, VP at Dexcom, Asia-Pacific.
The Dexcom G6 app for compatible iOS and Android devices* also allows patients to share their blood sugar information with up to ten subscribers‡, allowing families, loved ones and providers to provide healthcare services to monitor patients remotely for added peace of mind.Dexcom G6 features that empower users to take control of their health:
  • Elimination of fingersticks for calibration and diabetes treatment decisions
  • Continuous glucose readings are sent automatically using Bluetooth technology to any compatible smart device*, or to a Dexcom receiver, at five-minute intervals
  • Customizable alerts and alarms, including Urgent Low, Soon alert, which can warn users up to 20 minutes in advance of an urgent hypoglycemic event, so they can take steps to prevent it
  • Real-time data sharing with the Dexcom G6 app, allowing the user to share their glucose data with up to ten followers to monitor their glucose levels remotely for extra peace of mind
  • 10-day sensor allowing for longer wear
  • A slim transmitter with a lower profile for more discreet wearability
  • An auto-applicator designed to make sensor insertion simple with the touch of a button
  • A newly designed receiver with a touchscreen display (receiver/display device is optional)
  • New sensor membrane that enables acetaminophen use without any effect on glucose readings§
The Dexcom G6 CGM system connects to the Dexcom G6 App, available for download from the Apple App Store or Google Play Store, for use with a compatible Apple or Android smart device. Additionally, patients can view glucose readings on the optional Dexcom G6 Touch Screen Receiver which can be purchased separately.The Dexcom G6 CGM received approval from HSA Singapore late last year and is now available to Singaporeans this month.
Next Post

MIT SLOAN 2023 HEALTHCARE AND BIOINNOVATIONS CONFERENCE

February 24th 2023 | MIT Media Lab The MIT Sloan Healthcare & BioInnovations Conference is an annual event that brings together industry, academic, investment, and policy leaders from around the healthcare ecosystem to discuss key issues in the healthcare industry. Attendees will enjoy hearing from speakers and panelists from industry […]
thehealthco.info